http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104873471-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104873471-B
titleOfInvention A kind of RABEPRAZOLE SODIUM plain piece and sodium rabeprazole enteric-coated tablet
abstract The present invention provides a kind of RABEPRAZOLE SODIUM plain piece, in parts by weight, including:20 parts~40 parts of RABEPRAZOLE SODIUM;260 parts~300 parts of lactose;50 parts~80 parts of aluminium-magnesium silicate;35 parts~45 parts of magnesia;1 part~5 parts of microcrystalline cellulose.The present invention controls the component of RABEPRAZOLE SODIUM plain piece and the dosage of each component, by the comprehensive function between each component, RABEPRAZOLE SODIUM plain piece provided by the invention is had preferable dissolution rate, bioavailability is higher;And the composition design of RABEPRAZOLE SODIUM plain piece provided by the invention is reasonable.Test result indicates that the dissolution rate of RABEPRAZOLE SODIUM plain piece provided by the invention is 97.5%.Present invention also offers a kind of sodium rabeprazole enteric-coated tablet, is prepared by above-mentioned RABEPRAZOLE SODIUM plain piece;Since the RABEPRAZOLE SODIUM plain piece composition design that the present invention uses is reasonable, the sodium rabeprazole enteric-coated tablet for making to be prepared has preferable stability.
priorityDate 2015-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101389317-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14720269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67576337
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450086953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410634091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453030527
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453678473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152732532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505875

Total number of triples: 40.